Inventory Summary of Apex Biotechnology Corp.

Apex Biotechnology Corp.'s latest annual inventory in 2023 was 747.71 Million TWD , up 1.14% from previous year.
Apex Biotechnology Corp.'s latest quarterly inventory in 2024 Q2 was 689.04 Million TWD , down -0.82% from previous quarter.
Apex Biotechnology Corp. reported annual inventory of 739.25 Million TWD in 2022, up 17.61% from previous year.
Apex Biotechnology Corp. reported annual inventory of 628.58 Million TWD in 2021, up 24.59% from previous year.
Apex Biotechnology Corp. reported quarterly inventory of 689.04 Million TWD for 2024 Q2, down -0.82% from previous quarter.
Apex Biotechnology Corp. reported quarterly inventory of 748.8 Million TWD for 2023 Q3, down -2.73% from previous quarter.

Annual Inventory Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual Inventory of Apex Biotechnology Corp. (2023 - 2009)

Year	Inventory	Inventory Growth
2023	747.71 Million TWD	1.14%
2022	739.25 Million TWD	17.61%
2021	628.58 Million TWD	24.59%
2020	504.53 Million TWD	-1.9%
2019	514.3 Million TWD	-19.95%
2018	642.47 Million TWD	16.81%
2017	550.03 Million TWD	11.03%
2016	495.39 Million TWD	17.2%
2015	422.67 Million TWD	-15.18%
2014	498.31 Million TWD	-1.16%
2013	504.16 Million TWD	-12.08%
2012	573.42 Million TWD	14.78%
2011	499.58 Million TWD	37.37%
2010	363.68 Million TWD	11.55%
2009	326.02 Million TWD	0.0%

Year	Inventory	Inventory Growth
2024 Q1	694.73 Million TWD	-7.09%
2024 Q2	689.04 Million TWD	-0.82%
2023 Q3	748.8 Million TWD	-2.73%
2023 Q1	780.49 Million TWD	5.58%
2023 Q4	747.71 Million TWD	-0.15%
2023 Q2	769.81 Million TWD	-1.37%
2023 FY	747.71 Million TWD	1.14%
2022 Q2	667.05 Million TWD	2.95%
2022 FY	739.25 Million TWD	17.61%
2022 Q4	739.25 Million TWD	6.72%
2022 Q3	692.72 Million TWD	3.85%
2022 Q1	647.95 Million TWD	3.08%
2021 FY	628.58 Million TWD	24.59%
2021 Q2	507.88 Million TWD	5.92%
2021 Q3	583.19 Million TWD	14.83%
2021 Q4	628.58 Million TWD	7.78%
2021 Q1	479.51 Million TWD	-4.96%
2020 Q2	490.6 Million TWD	6.87%
2020 Q4	504.53 Million TWD	-0.76%
2020 FY	504.53 Million TWD	-1.9%
2020 Q1	459.05 Million TWD	-10.74%
2020 Q3	508.39 Million TWD	3.63%
2019 Q3	602.16 Million TWD	-5.03%
2019 FY	514.3 Million TWD	-19.95%
2019 Q1	628.11 Million TWD	-2.24%
2019 Q2	634.06 Million TWD	0.95%
2019 Q4	514.3 Million TWD	-14.59%
2018 Q4	642.47 Million TWD	-0.57%
2018 FY	642.47 Million TWD	16.81%
2018 Q3	646.18 Million TWD	11.8%
2018 Q2	577.96 Million TWD	5.43%
2018 Q1	548.21 Million TWD	-0.33%
2017 Q2	535.46 Million TWD	12.8%
2017 FY	550.03 Million TWD	11.03%
2017 Q4	550.03 Million TWD	-0.48%
2017 Q1	474.68 Million TWD	-4.18%
2017 Q3	552.67 Million TWD	3.22%
2016 Q2	416.51 Million TWD	-6.9%
2016 Q1	447.37 Million TWD	5.84%
2016 FY	495.39 Million TWD	17.2%
2016 Q4	495.39 Million TWD	3.79%
2016 Q3	477.3 Million TWD	14.59%
2015 Q3	414.21 Million TWD	-13.1%
2015 Q2	476.67 Million TWD	-2.09%
2015 FY	422.67 Million TWD	-15.18%
2015 Q1	486.82 Million TWD	-2.31%
2015 Q4	422.67 Million TWD	2.04%
2014 FY	498.31 Million TWD	-1.16%
2014 Q4	498.31 Million TWD	-7.07%
2014 Q3	536.23 Million TWD	2.18%
2014 Q2	524.79 Million TWD	7.01%
2014 Q1	490.4 Million TWD	-2.73%
2013 Q2	457.2 Million TWD	-4.38%
2013 Q1	478.16 Million TWD	-16.61%
2013 FY	504.16 Million TWD	-12.08%
2013 Q4	504.16 Million TWD	7.19%
2013 Q3	470.33 Million TWD	2.87%
2012 Q2	517.58 Million TWD	0.53%
2012 FY	573.42 Million TWD	14.78%
2012 Q4	573.42 Million TWD	5.99%
2012 Q3	540.99 Million TWD	4.52%
2012 Q1	514.86 Million TWD	3.06%
2011 Q2	410.37 Million TWD	6.47%
2011 Q3	434.85 Million TWD	5.97%
2011 FY	499.58 Million TWD	37.37%
2011 Q4	499.58 Million TWD	14.88%
2011 Q1	385.44 Million TWD	5.98%
2010 Q4	363.68 Million TWD	0.0%
2010 FY	363.68 Million TWD	11.55%
2009 FY	326.02 Million TWD	0.0%

Peer Inventory Comparison of Apex Biotechnology Corp.

Name	Inventory	Inventory Difference
Sinphar Pharmaceutical Co.,Ltd.	839.19 Million TWD	10.901%
Panion & Bf Biotech Inc.	538.09 Million TWD	-38.955%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	1.21 Billion TWD	38.258%
GenMont Biotech Incorporation	88.11 Million TWD	-748.537%
Abnova (Taiwan) Corporation	408.3 Million TWD	-83.128%
Adimmune Corporation	526.4 Million TWD	-42.041%
Tanvex BioPharma, Inc.	108.28 Million TWD	-590.506%
Polaris Group	36.35 Million TWD	-1956.702%
Energenesis Biomedical CO.,LTD.	733 Thousand TWD	-101907.367%
UnicoCell Biomed Co., Ltd.	5.45 Million TWD	-13617.006%
PELL Bio-Med Technology Co. Ltd.	3.76 Million TWD	-19770.157%

Global Stocks Search

Apex Biotechnology Corp. (1733.TW)

Inventory Summary of Apex Biotechnology Corp.

Annual Inventory Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual Inventory of Apex Biotechnology Corp. (2023 - 2009)

Peer Inventory Comparison of Apex Biotechnology Corp.